PR GLP-18 CLINICFORCLINICFOR GLP-1 GLP-1 GLP-1 GLP-18 800 800 GLP-18002.5mg8,000OFF19,115116372 1OK LINE3 INJE8000 1 2.5mg1INJE8000227,1151,10011 2 19,115301637 3 GLP-1 GLP-1 GLP-1 PC 24 GLP-1 3 GLP-1 GLP-1 LINE GLP-1 GLP-18 GLP-18 1 1,650 2 1,100 3 2.5mg1INJE800021,10011 4 eLifeeLife2 8001 3 1 20204202512 800 GLP-13 2.5mgINJE80008,000OFF19,115 724 2 3 1,650 4 2.5mg1INJE800021,10011 DMM 5GLP-1 24 150 DMMDMH GLP-15 2.5mg45,00025,9001 1502 1 GLP-1 11(1)dietmounjaro5,000OFF25,900230,9005501 2 2022420255DMM 4 24LINE 15 24365 GLP-14 15 LINE24 eLife 6GLP-1 LINE eLife GLP-16 LINE GLP-1 2.5mg5mg7.5mgeLife2 3 40 40 GLP-13 3 15 GLP-13 15 1 GLP-1 GLP-11 LINE GLP-1 GLP-1 GLP-1GLP-1 GLP-1 () GLP-1 11GLP-1 3mg7mg14mg3 1GLP-1 GIPGLP-12 1 15mg 1OK 1GLP-1 2mg1118,00025,000 12mg118,00025,000 1 GLP-1 0.5mg22,00025,000 GLP-1 2.5mg15,00040,000 1GLP-1 0.3mg 0.6mg3015,00025,000 118mg115,00025,000 1GLP-1 3.0mg 0.6mg3015,00025,000 118mg115,00025,000 GLP-1 GLP-1 GLP-1 1 GLP-1 GLP-1 1 GLP-15STEP GLP-15 STEP1 GLP-1 STEP2 STEP3 STEP4 STEP5 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 GLP-1 2 GLP-1 GLP-18 800 8002.5mg8,000OFF19,115116372 1OK LINE3 INJE8000 1 2.5mg1INJE8000227,1151,10011 2 19,115301637 3

Intramuscular administration at 800 ng/kg achieved a 65.6% inhibition ratio of ulcer formation, outperforming famotidines 57.2% rate
Akoglu, and Gl N
Aromatase inhibitors and tamoxifen are associated with shifts in body composition, with reductions in lean muscle mass and increases in fat mass, even when overall weight stays roughly the same
doi:10.1016/S2213-8587(18)30024-X Ahrn B, Masmiquel L, Kumar H, et al
Eating smaller portions and staying away from greasy foods made a big difference